Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry-Reference-Cited by-同舟云学术

Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry

Published:2021-06 Issue: Volume:25 Page:346-350
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Zhanel George G.,Dhami Rita,Baxter Melanie,Kosar Justin,Cervera Carlos,Irfan Neal,Zvonar Rosemary,Borgia Sergio,Tessier Jean-Francois,Dow Gordon,Ariano Robert,Dube Maxime,Savoie Michel,Bassetti Matteo,Walkty Andrew,Karlowsky James A.

Funder

Merck Canada Inc

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference20 articles.

1. Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant Gram-negative bacilli;Zhanel;Drugs,2014

2. 42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study;Zhanel;J Antimicrob Chemother,2019

3. Ceftolozane/tazobactam for pulmonary exacerbation in a 63-year-old cystic fibrosis patient with renal insufficiency and an elevated MIC to Pseudomonas aeruginosa;Romano;IDCases,2020

4. Efficacy and safety of ceftolozane/tazobactam as a therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: a case series from a single center experience;Buonomo;Infection,2020

5. Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature;Meschiari;Infection,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry;Journal of Global Antimicrobial Resistance;2024-09

2. How is ceftobiprole used in Canada: the CLEAR study final results;Expert Review of Anti-infective Therapy;2024-07-15

3. Introducing the UK Antimicrobial Registry (UKAR) study: providing real world data on new antimicrobials to support antimicrobial stewardship and tackle antimicrobial resistance;JAC-Antimicrobial Resistance;2024-07-03

4. Novel Siderophore Cephalosporin and Combinations of Cephalosporins with β-Lactamase Inhibitors as an Advancement in Treatment of Ventilator-Associated Pneumonia;Antibiotics;2024-05-14

5. Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) in Canada: treatment update and the role of new IV antimicrobials;Expert Review of Anti-infective Therapy;2023-10-13